Cargando…
Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants
Post‐transplant lymphoproliferative disorders (PTLDs) are life‐threatening neoplasms after organ transplantation. Because of their rarity and multiple grades of malignancy, the incidence, outcomes, and clinicopathological features affecting patient survival after liver transplantation (LT) remain un...
Autores principales: | Tajima, Tetsuya, Hata, Koichiro, Haga, Hironori, Nishikori, Momoko, Umeda, Katsutsugu, Kusakabe, Jiro, Miyauchi, Hidetaka, Okamoto, Tatsuya, Ogawa, Eri, Sonoda, Mari, Hiramatsu, Hidefumi, Fujimoto, Masakazu, Okajima, Hideaki, Takita, Junko, Takaori‐Kondo, Akifumi, Uemoto, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453854/ https://www.ncbi.nlm.nih.gov/pubmed/33655645 http://dx.doi.org/10.1002/lt.26034 |
Ejemplares similares
-
Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation
por: Okamoto, Tatsuya, et al.
Publicado: (2022) -
Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019) -
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022) -
Prognostic index consisting of early post‐transplant variables <2 weeks in adult living‐donor liver transplantation
por: Kusakabe, Jiro, et al.
Publicado: (2020) -
Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
por: Tajima, Tetsuya, et al.
Publicado: (2023)